Advertisement
Advertisement
CDIO
Cardio Diagnostics Holdings Inc. Common stock
1.67
USDSponsored
-0.04
-2.34%
Nov 18, 09:30 UTC -5
Open
Cardio Diagnostics Holdings Inc. Common stock (CDIO) Earnings
CDIO Earnings Reports
Positive Surprise Ratio
CDIO beat 9 of 11 last estimates.
82%
Next Report
Date of Next Report
--
Estimate for Q-- -- (Revenue/ EPS)
--
/--
Implied change from Q3 26 (Revenue/ EPS)
--
/--
Implied change from Q-- -- (Revenue/ EPS)
--
/--
Cardio Diagnostics Holdings Inc. Common stock earnings per share and revenue
On Nov 10, 2026, CDIO reported earnings of -- USD per share (EPS) for Q3 26, -- the estimate of -- USD, resulting in a --% surprise. Revenue reached --, compared to an expected --, with a --% difference.
Looking ahead to -- --, -- analysts forecast an EPS of -- USD, with revenue projected to reach -- USD, implying an -- of --% EPS, and -- of --% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

Rein Therapeutics, Inc. Common Stock
Report Date
Nov 16, 2026 For Q3 26
Estimate
-$0.10
Actual
-$0.06
Surprise
+41.18%

Instil Bio, Inc. Common Stock
Report Date
Nov 16, 2026 For Q3 26
Estimate
-$0.17
Actual
-$0.62
Surprise
-261.09%

Connect Biopharma Holdings Limited Ordinary Shares
Report Date
Nov 16, 2026 For Q3 26
Estimate
-$0.27
Actual
-$0.26
Surprise
+4.59%

Jasper Therapeutics, Inc. Common Stock
Report Date
Nov 16, 2026 For Q3 26
Estimate
-$3.02
Actual
-$13.97
Surprise
-361.93%

Dare Bioscience, Inc. Common Stock
Report Date
Nov 16, 2026 For Q3 26
Estimate
-$0.26
Actual
-$0.18
Surprise
+32.13%

GT Biopharma Inc. Common Stock
Report Date
Nov 16, 2026 For Q3 26
Estimate
-$2.54
Actual
-$1.98
Surprise
+22.35%

Lantern Pharma Inc. Common Stock
Report Date
Nov 17, 2026 For Q3 26
Estimate
-$0.35
Actual
-$0.81
Surprise
-126.89%

Pulmatrix, Inc. Common Stock
Report Date
Nov 17, 2026 For Q3 26
Estimate
-Actual
-$0.34
Surprise
-

HCW Biologics Inc. Common Stock
Report Date
Nov 16, 2026 For Q3 26
Estimate
-$1.37
Actual
-$1.53
Surprise
-11.11%

Aptevo Therapeutics Inc
Report Date
Nov 16, 2026 For Q3 26
Estimate
-$3.78
Actual
-$5.19
Surprise
-36.96%
FAQ
What were Cardio Diagnostics Holdings Inc. Common stock's earnings and revenue for the latest quarter Q3 2026?
For Q3 2026, Cardio Diagnostics Holdings Inc. Common stock reported EPS of --, missing estimates by --, and revenue of --, -- -- expectations.
How did the market react to Cardio Diagnostics Holdings Inc. Common stock's Q3 2026 earnings?
The stock price moved -- --, changed from -- before the earnings release to -- the day after.
When is Cardio Diagnostics Holdings Inc. Common stock expected to report next?
The next earning report is scheduled for --.
What are the forecasts for Cardio Diagnostics Holdings Inc. Common stock's next earnings report?
Based on --
analysts, Cardio Diagnostics Holdings Inc. Common stock is expected to report EPS of -- and revenue of -- for Q-- --.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.